Hypoxic burden and sleep hypoventilation in obese patients.

Capnography Hypercapnia Polygraphy Transcutaneous CO(2) monitoring

Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
08 Sep 2024
Historique:
received: 28 06 2024
revised: 13 08 2024
accepted: 07 09 2024
medline: 15 9 2024
pubmed: 15 9 2024
entrez: 14 9 2024
Statut: aheadofprint

Résumé

Novel biomarkers of hypoxic load have emerged, as sleep apnea-specific hypoxic burden which provides more precise assessment of intermittent hypoxemia severity. Our main objective was to assess the potential benefit of hypoxic burden to identify obesity-related sleep hypoventilation. We hypothesized that hypoxic burden may help diagnose obesity-related sleep hypoventilation better than usual sleep respiratory measures (i.e., apnea-hypopnea index (AHI), mean SpO This retrospective study was conducted from June 2022 to October 2023 at the University Hospital of Rouen, France. All consecutive obese patients (BMI ≥30 kg/m Among 107 obese patients with analyzed capnography, 37 (35 %) had sleep hypoventilation. Patients were 53 ± 14 years old, mean BMI = 38 ± 6 kg/m Hypoxic burden has low correlation with transcutaneous CO

Identifiants

pubmed: 39276698
pii: S1389-9457(24)00429-5
doi: 10.1016/j.sleep.2024.09.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-57

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

L Beauvais (L)

CHU Rouen, Department of Pulmonary, Thoracic Oncology and Respiratory Intensive Care, FR-76000 Rouen, France.

A Gillibert (A)

CHU Rouen, Department of Biostatistics, FR-76000 Rouen, France.

A Cuvelier (A)

CHU Rouen, Department of Pulmonary, Thoracic Oncology and Respiratory Intensive Care, FR-76000 Rouen, France; Normandie Univ, UNIROUEN, UR 3830 GRVHN, Rouen Institute for Research and Innovation in Biomedicine (IRIB), FR-76000 Rouen, France.

E Artaud-Macari (E)

CHU Rouen, Department of Pulmonary, Thoracic Oncology and Respiratory Intensive Care, FR-76000 Rouen, France; Normandie Univ, UNIROUEN, UR 3830 GRVHN, Rouen Institute for Research and Innovation in Biomedicine (IRIB), FR-76000 Rouen, France.

M-A Melone (MA)

CHU Rouen, Department of Pulmonary, Thoracic Oncology and Respiratory Intensive Care, FR-76000 Rouen, France; Normandie Univ, UNIROUEN, UR 3830 GRVHN, Rouen Institute for Research and Innovation in Biomedicine (IRIB), FR-76000 Rouen, France. Electronic address: marieanne.melone@chu-rouen.fr.

Classifications MeSH